The Trial Capacity Awards (2023) funded by the ALS Association support efforts to improve the speed and efficiency of clinical trial conduct at both established and emerging clinical trial sites across the U.S., as well as initiatives to help improve trial accessibility for people with ALS. Applicants must be based at U.S. public and private non-profit entities, such as ALS clinics, universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government. This funding provides $400,000 USD (including 10% indirect costs) for up to 4 years.
Letters of intent are due on June 8, 2023. Full applications are by invitation only and due on August 10, 2023.